12/01/2026
Woo Woo! Welcome aboard the ENDIA Team train to Stacey Findlay! Stacey is ENDIA’s new coeliac nurse helping our research coordinators with all the data and samples specific to antibodies (CA) and (CD).
CD and (T1D) are both autoimmune conditions where, for some reason, the body attacks healthy cells (small intestine and pancreatic cells respectively). Both conditions share a common genetic background linked to the human leukocyte antigen ( ) genotype. Approximately 95% of individuals with and nearly 99% of those with CD carry the genes DQ2 and DQ8. Reassuringly, most people with these high-risk genes do not develop T1D or coeliac disease.
That said, a systematic review and meta-analysis conducted in 2014 (https://doi.org/10.1111/apt.12973) found more than one in twenty people with have coeliac disease. This prevalence is high enough to also for coeliac disease among those at risk of, or living with, type 1 diabetes. Asymptomatic coeliac antibodies can often be detected in those with type 1 diabetes, and vice versa.
This is why ENDIA also tests for . We are also seeking an additional sample of intestinal cells collected during a routine diagnostic biopsy by a gastroenterologist. The sample collected during diagnostic biopsy for ENDIA is precious because no one has collected this sample for research before! So, if your child is recommended a diagnostic , please consider consenting to the additional cell collection for ENDIA. It’s effectively one additional swipe of five already collected to make the diagnosis.
For more information or questions about our , speak with your coordinator, or contact Stacey or Jayne via endiacoeliac@wehi.edu.au